 NEW YORK, June 1, 2021 PRNewswire -- Relmada Therapeutics, Inc. Nasdaq: RLMD, a late-stage biotechnology company addressing diseases of the central nervous system CNS, today announced that Sergio Traversa, Chief Executive Officer of Relmada, is scheduled to participate in a fireside chat at Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 10:30 am Eastern Time. Participants may access a live webcast of the event through the following link: The webcast can also be accessed in the Investors section of the Relmada website at 